Although RSV is a frequent cause of acute respiratory infections (ARIs), an estimation of its incidence has proven challenging due to a lack of routine testing, overlapping clinical presentations with ...

KRIS 6 News spoke with Shayleigh Sprague about her daughters experience with Respiratory Syncytial Virus (RSV). KRIS 6 News spoke with Dr. Jamie Fergie, an Infectious Disease Doctor at Driscoll ...

The 2022–23 “tripledemic” season—in which influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) all surged at the same time—was especially bad for Arizona, says Efrem Lim, an Arizona State ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

Co-administration was also well tolerated, with acceptable reactogenicity and safety profiles. Results from this trial will be submitted for peer-reviewed scientific publication and will be used to ...

A vaccine for adults 60 years and older was approved by the FDA for protection against respiratory syncytial virus, making it the first such vaccine to be approved worldwide. The FDA has approved ...

This story was originally published in 2022; it has since been updated. It started with a tickle in your throat. Then, it evolved into congestion, and maybe a little cough. Perhaps you lost your voice ...

Last year’s respiratory illness season was unprecedented with the highest flu hospitalizations in a decade, a peak of respiratory syncytial virus (RSV) cases 60 percent higher than the previous year, ...

What is mResvia used for? mResvia (respiratory syncytial virus vaccine) is commonly given to help prevent lower respiratory tract disease (such as pneumonia or bronchiolitis) caused by respiratory ...